.png){kind=icon}
.png){kind=icon}
Return
Nationwide Centralized Manufacturing and Fresh Distribution of TCRαβ/CD19-DepletedGrafts: A Real-World French Experience
.png){kind=icon}
PRE
AI
U
M
E
C
M
E
A
C
C
B
M
E
F
D
V
A
B
C
A
N
DOI：10.1016/j.jtct.2026.05.035.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
• One academic center delivered fresh engineered grafts across France • 52 of 55 grafts met the 36-hour vein-to-vein target • Heterogeneous starting materials still yielded compliant final grafts • Centralized manufacturing ensured robust TCRαβ/CD19 depletion • This model can broaden access to complex graft engineering
Journal
IF:
4.4
Papers:
2.1K
Citations:
4.4K
Organization
No organization information available
Cited Papers